blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3981770

EP3981770 - CDK INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.01.2024
Database last updated on 19.10.2024
FormerExamination is in progress
Status updated on  24.03.2023
FormerRequest for examination was made
Status updated on  14.10.2022
FormerThe application has been published
Status updated on  11.03.2022
Most recent event   Tooltip26.01.2024Application deemed to be withdrawnpublished on 28.02.2024  [2024/09]
Applicant(s)For all designated states
G1 Therapeutics, Inc.
700 Park Offices Drive, Suite 200
Research Triangle Park, NC 27709 / US
[2022/15]
Inventor(s)01 / TAVARES, Francis, X.
Chapel Hill, 27599-7295 / US
02 / STRUM, Jay C.
Chapel Hill, 27599-729 / US
 [2022/15]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2022/15]
Application number, filing date21184036.825.10.2011
[2022/15]
Priority number, dateUS201040649810P25.10.2010         Original published format: US 40649810 P
[2022/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3981770
Date:13.04.2022
Language:EN
[2022/15]
Search report(s)(Supplementary) European search report - dispatched on:EP11.02.2022
ClassificationIPC:C07D487/14, C07D487/20, C07D519/00, A61K31/519, A61P35/00
[2022/15]
CPC:
C07D487/20 (EP,CN,IL,RU,US); C07D487/14 (EP,CN,IL,KR,RU,US); A61K31/499 (KR);
A61P35/00 (EP,KR,US); C07D498/14 (KR); C07D519/00 (EP,CN,IL,KR,US);
A61K31/519 (RU) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/46]
Former [2022/15]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:CDK-HEMMER[2022/15]
English:CDK INHIBITORS[2022/15]
French:INHIBITEURS DE CDK[2022/15]
Examination procedure13.10.2022Examination requested  [2022/46]
13.10.2022Date on which the examining division has become responsible
16.01.2023Amendment by applicant (claims and/or description)
28.03.2023Despatch of a communication from the examining division (Time limit: M06)
10.10.2023Application deemed to be withdrawn, date of legal effect  [2024/09]
02.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/09]
Parent application(s)   TooltipEP11838545.9  / EP2632467
EP16168485.7  / EP3118203
EP18167945.7  / EP3381920
EP19164126.5  / EP3567042
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
16.01.2023Request for further processing filed
16.01.2023Full payment received (date of receipt of payment)
Request granted
25.01.2023Decision despatched
Fees paidRenewal fee
08.11.2021Renewal fee patent year 03
08.11.2021Renewal fee patent year 04
08.11.2021Renewal fee patent year 05
08.11.2021Renewal fee patent year 06
08.11.2021Renewal fee patent year 07
08.11.2021Renewal fee patent year 08
08.11.2021Renewal fee patent year 09
08.11.2021Renewal fee patent year 10
08.11.2021Renewal fee patent year 11
15.09.2022Renewal fee patent year 12
13.09.2023Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2004104007  (PHARMACIA ITALIA SPA [IT], et al) [A] 1-15* page 1, line 21 - line 25; claim 1 *;
 [AD]WO2010020675  (NOVARTIS AG [CH], et al) [AD] 1-15 * claims 1,13 *
by applicantWO2005040166
 WO2010020675
    - WHITE, J. D. et al., J. Org. Chem., (19950000), vol. 60, page 3600
    - SCHOENAUER, KZBIRAL, E., Tetrahedron Letters, (19830000), vol. 24, page 573
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.